COTUGNO, NICOLA
 Distribuzione geografica
Continente #
NA - Nord America 11.625
AS - Asia 3.164
EU - Europa 2.316
SA - Sud America 528
Continente sconosciuto - Info sul continente non disponibili 400
AF - Africa 68
OC - Oceania 7
Totale 18.108
Nazione #
US - Stati Uniti d'America 11.331
SG - Singapore 1.499
IT - Italia 720
CN - Cina 513
BR - Brasile 416
HK - Hong Kong 356
RU - Federazione Russa 343
VN - Vietnam 249
DE - Germania 210
IE - Irlanda 209
BD - Bangladesh 193
FI - Finlandia 143
SE - Svezia 132
CA - Canada 127
GB - Regno Unito 127
FR - Francia 124
JP - Giappone 89
UA - Ucraina 88
IN - India 81
NL - Olanda 60
AR - Argentina 40
AT - Austria 40
MX - Messico 39
PL - Polonia 35
ID - Indonesia 31
KR - Corea 31
TR - Turchia 29
ZA - Sudafrica 27
ES - Italia 22
CO - Colombia 19
CR - Costa Rica 19
EC - Ecuador 19
TT - Trinidad e Tobago 18
GP - Guadalupe 14
NI - Nicaragua 14
CZ - Repubblica Ceca 13
GT - Guatemala 13
IQ - Iraq 13
HN - Honduras 11
SA - Arabia Saudita 11
SV - El Salvador 11
JM - Giamaica 10
VE - Venezuela 10
KE - Kenya 9
MA - Marocco 9
AU - Australia 7
JO - Giordania 7
PH - Filippine 7
PR - Porto Rico 7
CL - Cile 6
CW - ???statistics.table.value.countryCode.CW??? 6
EG - Egitto 6
GR - Grecia 6
KG - Kirghizistan 6
PK - Pakistan 6
PY - Paraguay 6
UY - Uruguay 6
CH - Svizzera 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
BE - Belgio 4
DZ - Algeria 4
MY - Malesia 4
NP - Nepal 4
PA - Panama 4
PE - Perù 4
RO - Romania 4
TH - Thailandia 4
TN - Tunisia 4
AL - Albania 3
BG - Bulgaria 3
GH - Ghana 3
IR - Iran 3
MD - Moldavia 3
OM - Oman 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
CY - Cipro 2
DM - Dominica 2
EE - Estonia 2
HU - Ungheria 2
IL - Israele 2
LB - Libano 2
LT - Lituania 2
LV - Lettonia 2
MK - Macedonia 2
PS - Palestinian Territory 2
RS - Serbia 2
TW - Taiwan 2
AI - Anguilla 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CU - Cuba 1
DK - Danimarca 1
ET - Etiopia 1
Totale 17.701
Città #
Wilmington 2.064
Houston 1.648
Woodbridge 1.598
Singapore 894
Ashburn 643
San Jose 580
Fairfield 355
Hong Kong 351
Chandler 344
Beijing 240
Rome 223
Council Bluffs 219
Dublin 184
The Dalles 156
Santa Clara 150
Los Angeles 145
New York 145
Medford 144
Seattle 137
Cambridge 124
Ann Arbor 95
Helsinki 93
Tokyo 86
Buffalo 85
Ho Chi Minh City 80
Lawrence 63
Munich 63
Lauterbourg 61
Jacksonville 59
Milan 55
Denver 53
Chicago 52
Engelhard 51
North Bergen 50
Hanoi 49
Dallas 48
Phoenix 47
Montreal 46
San Diego 41
Nuremberg 40
São Paulo 40
Atlanta 32
London 31
Moscow 31
Frankfurt am Main 29
Orem 29
Lappeenranta 26
Toronto 26
Warsaw 26
Brooklyn 25
Redondo Beach 24
St. George 23
Pune 22
Naples 21
Seoul 21
Jakarta 20
Dearborn 19
Salt Lake City 19
Johannesburg 18
Turin 18
Creede 17
Norwalk 17
San Francisco 16
Stockholm 16
Tampa 15
Vienna 15
Chennai 14
Managua 14
Menlo Park 14
New Orleans 13
San José 13
Da Nang 12
Rio de Janeiro 12
Boston 11
Brno 11
Guatemala City 11
San Salvador 11
Amsterdam 10
Boardman 10
Brasília 10
Detroit 10
Galveston 10
Mexico City 10
Poplar 10
Turku 10
Ankara 9
Bologna 9
Colorado Springs 9
Dhaka 9
Miami 9
Monte Vista 9
Mülheim 9
Querétaro 9
The Bronx 9
Elk Grove Village 8
Florence 8
Haiphong 8
Nepi 8
Pittsburgh 8
Shanghai 8
Totale 12.502
Nome #
A 2-month-old male with pyuria and persistent fever 533
Antibody but not memory B-cell responses are tuned-down in vertically HIV-1 infected children and young individuals being vaccinated yearly against influenza 507
Safety and immunogenicity of a monovalent MF59®-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults 485
Early Highly Active Antiretroviral Therapy Enhances B-cell Longevity 470
Downfall of the current antibody correlates of influenza vaccine response in yearly vaccinated subjects: Toward qualitative rather than quantitative assays 467
Premature aging of the immune system relates with increased anti-lymphocyte antibodies (ALA) after an immunization in HIV-1 infected and kidney transplanted patients 455
Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment 449
Premature immune senescence during HIV-1 vertical infection relates with response to influenza vaccination 439
Raising awareness of non-hodgkin lymphoma in HIV-infected adolescents: Report of 2 cases in the HAART era 438
Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease 434
Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions 401
Perturbation of B cell gene expression persists in HIV-infected children despite effective antiretroviral therapy and predicts H1N1 response 361
Paediatric HIV infection in the 'omics era: defining transcriptional signatures of viral control and vaccine responses 350
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children 343
Impaired X-CGD T cell compartment is gp91phox-NADPH oxidase independent 236
Phenotypical T Cell Differentiation Analysis: A Diagnostic and Predictive Tool in the Study of Primary Immunodeficiencies 232
Distinct gut microbiota profile in antiretroviral therapy-treated perinatally HIV-infected patients associated with cardiac and inflammatory biomarkers 223
Artificial Intelligence Applied to in vitro Gene Expression Testing (IVIGET) to Predict Trivalent Inactivated Influenza Vaccine Immunogenicity in HIV Infected Children 222
Novel Compound Heterozygous Mutations in IL-7 Receptor α Gene in a 15-Month-Old Girl Presenting With Thrombocytopenia, Normal T Cell Count and Maternal Engraftment. 210
Waning of vaccine-induced immunity to measles in kidney transplanted children 196
null 192
Prolonged impairment of immunological memory after Anti-CD20 treatment in pediatric idiopathic nephrotic syndrome 190
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children 190
DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study. 187
Human Immunodeficiency Virus (HIV)-Antibody repertoire estimates reservoir size and time of antiretroviral therapy initiation in virally suppressed perinatally HIV-infected children 184
Severe parainfluenza pneumonia in a case of transient hypogammalobulinemia of infancy 183
Report from the First EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children's Actual Life with Novel Immunotherapeutic Strategies) General Assembly meeting, 9-11 November 2017, Rome, Italy 172
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies 170
How to dissect the plasticity of antigen specific immune response: a tissue perspective 170
Early ART-treated perinatally HIV-infected seronegative children demonstrate distinct long-term persistence of HIV-specific T and B cell memory 166
Clinical, Immunological, and Molecular Variability of RAG Deficiency: A Retrospective Analysis of 22 RAG Patients 159
High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries 153
Pre-vaccination immune markers predict response to BNT162b2 mRNA vaccine in vulnerable groups – The CONVERS project, report from a pediatric tertiary hospital 153
Partial T cell defects and expanded CD56bright NK cells in an SCID patient carrying hypomorphic mutation in the IL2RG gene 150
The mission is remission: Hope for controlling HIV replication without ART in early-treated perinatally HIV-infected children 147
Enhancement of neuroblastoma NK-cell-mediated lysis through NF-kB p65 subunit-induced expression of FAS and PVR, the loss of which is associated with poor patient outcome 147
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed? 138
Premature B-cell senescence as a consequence of chronic immune activation: Implications for vaccination of immune compromised individuals 137
Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine 132
Epstein–Barr virus-associated smooth muscle tumor in a female with ataxia telangiectasia: a case report 130
Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology 126
Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference 126
Induction of il21 in peripheral t follicular helper cells is an indicator of influenza vaccine response in a previously vaccinated HIV-infected pediatric cohort 125
Tailored treatments in inborn errors of immunity associated with atopy (IEIs-A) with skin involvement 124
OMIC Technologies and vaccine development: From the identification of vulnerable individuals to the formulation of invulnerable vaccines 122
Distinct pro-inflammatory/pro-angiogenetic signatures distinguish children with Long COVID from controls 121
Shielding the immunocompromised: COVID-19 prevention strategies for patients with primary and secondary immunodeficiencies 120
Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies 119
Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults 118
B-cell immunity and vaccine induced antibody protection reveal the inefficacy of current vaccination schedule in infants with perinatal HIV-infection in Mozambique, Africa 117
Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment 116
Active prophylaxis for respiratory syncytial virus: Current knowledge and future perspectives 116
COVID-19 in children: From afterthought to unknown 116
Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens 113
Safety and Long-Term Immunogenicity of BNT162b2 Vaccine in Individuals with Down Syndrome 113
Use of dupilumab for atopic dermatitis in pediatric and young adult patients with inborn errors of immunity 112
Reduced Time to Suppression Among Neonates With HIV Initiating Antiretroviral Therapy Within 7 Days After Birth 112
The Clinical Course of SARS-CoV-2 Infection in Patients With Autoimmune Neutropenia: A Retrospective Case Series Study 111
Development of Psychological Problems Among Adolescents During School Closures Because of the COVID-19 Lockdown Phase in Italy: A Cross-Sectional Survey 110
Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors 109
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 109
Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination 108
T cell immune discriminants of HIV reservoir size in a pediatric cohort of perinatally infected individuals 108
Highly specific memory b cells generation after the 2nd dose of bnt162b2 vaccine compensate for the decline of serum antibodies and absence of mucosal iga 108
Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait? 107
Accelerated CD8+ T cell maturation in infants with perinatal HIV infection 107
Paradoxical aging in HIV: Immune senescence of B Cells is most prominent in young age 107
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy 107
The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection 106
Multi-modal immune dynamics of pre-COVID-19 Kawasaki Disease following intravenous immunoglobulin 106
Similarities and differences between myocarditis following COVID-19 mRNA vaccine and multiple inflammatory syndrome with cardiac involvement in children 103
Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity 103
Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome: an extended follow-up 102
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission 101
A case of purulent pericarditis caused by Haemophilus influenzae serotype b 101
Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium 100
Relapsing myocarditis following initial recovery of post COVID-19 vaccination in two adolescent males – Case reports 100
Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART 99
Early and Highly Suppressive Antiretroviral Therapy Are Main Factors Associated With Low Viral Reservoir in European Perinatally HIV-Infected Children 99
Caregivers’ psychosocial assessment for identifying HIV-infected infants at risk of poor treatment adherence: an exploratory study in southern Mozambique 98
Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort) 98
Actinomyces timonensis A Novel Pathogen to Not Overlook in Immunocompetent Children With Recurrent Cutaneous Abscesses 97
Case Report: The impact of severe cryptosporidiosis on the gut microbiota of a pediatric patient with CD40L immunodeficiency 96
Impact of Early Antiretroviral Therapy Initiation on HIV-Specific CD4 and CD8 T Cell Function in Perinatally Infected Children 96
Comprehensive and safe school strategy during COVID-19 pandemic 96
Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART 94
Monocytes across life span in hiv infection: Lights and shadows 93
Clinical, Virological and Immunological Subphenotypes in a Cohort of Early Treated HIV-Infected Children 91
Multisystem Inflammatory Syndrome in Children in Western Countries? Decreasing Incidence as the Pandemic Progresses?: An Observational Multicenter International Cross-sectional Study 90
Exploring nasopharyngeal microbiota profile in children affected by SARS-CoV-2 infection 90
Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report 90
The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV 90
Emerging insights into atypical B cells in pediatric chronic infectious diseases and immune system disorders: T(o)-bet on control of B-cell immune activation 89
Two Pediatric Cases of Multisystem Inflammatory Syndrome with Overlapping Neurological Involvement Following SARS-CoV-2 Vaccination and Unknown SARS-CoV2 Infection: The Importance of Pre-Vaccination History 89
Efficacy of CytoSorb in a Pediatric Case of Severe Multisystem Infammatory Syndrome (MIS-C): A Clinical Case Report 89
Viral Response among Early Treated HIV Perinatally Infected Infants: Description of a Cohort in Southern Mozambique 89
Early inflammation as a footprint of increased mortality risk in infants living with HIV from three African countries 88
Higher Troponin Levels on Admission are associated With Persistent Cardiac Magnetic Resonance Lesions in Children Developing Myocarditis After mRNA-Based COVID-19 Vaccination 87
Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile 84
Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers 84
Totale 16.946
Categoria #
all - tutte 71.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022671 0 0 0 21 108 50 8 19 172 34 65 194
2022/2023948 73 84 14 94 76 197 151 51 122 3 53 30
2023/2024539 33 92 25 4 53 153 35 15 14 23 31 61
2024/20252.547 70 476 244 166 52 221 161 179 261 292 236 189
2025/20264.891 400 261 493 419 402 191 714 564 487 407 309 244
2026/20271.939 321 224 736 658 0 0 0 0 0 0 0 0
Totale 18.108